M&A Deal Summary

ADVANZ PHARMA Acquires Amdipharm Mercury - AMCo.

On September 8, 2015, ADVANZ PHARMA acquired life science company Amdipharm Mercury - AMCo. from Cinven for 3.5B USD

Acquisition Highlights
  • This is ADVANZ PHARMA’s 2nd transaction in the Life Science sector.
  • This is ADVANZ PHARMA’s largest (disclosed) transaction.
  • This is ADVANZ PHARMA’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2015-09-08
Target Amdipharm Mercury - AMCo.
Sector Life Science
Buyer(s) ADVANZ PHARMA
Sellers(s) Cinven
Deal Type Add-on Acquisition
Deal Value 3.5B USD

Target

Amdipharm Mercury - AMCo.

Croydon, United Kingdom
Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ADVANZ PHARMA

London, United Kingdom
Category Company
Founded 1963
Sector Life Science
Employees675
Revenue 508M USD (2019)
DESCRIPTION

ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines with direct sales access in Europe and a global distribution network. ADVANZ PHARMA was founded in 1963 and is based in London, United Kingdom.

DEAL STATS #
Overall 4 of 6
Sector (Life Science) 2 of 4
Type (Add-on Acquisition) 2 of 3
Country (United Kingdom) 1 of 1
Year (2015) 2 of 2
Size (of disclosed) 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-15 Covis Pharma Sàrl

Luxembourg, Switzerland

Covis Pharma is a specialty pharmaceutical company providing therapeutic solutions to patients. Covis markets a portfolio of U.S. prescription products through its U.S. sales and distribution affiliate, Covis Pharmaceuticals, Inc. which is headquartered in Cary, North Carolina.

Buy $1.2B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-05 Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection

Oakville, Ontario, Canada

Fortaz®, ZinacefTM, and Zantac® Injection are the products used in specialty generic pharma.

Sell $10M

Seller(S) 1

SELLER

Cinven

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1977
PE ASSETS 39.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Cinven is a private equity firm focused on buyout investments in growing, profitable businesses located throughout Europe and North America. Sectors of interest include business and financial services, healthcare, industrial, retail, leisure, consumer, technology, media, and telecommunications. Cinven looks to invest a minimum of €200 million in companies with minimum enterprise values of €400 million. Cinven does not invest in start-ups or development phase companies. Cinven was established in 1977 and is headquartered in London.

DEAL STATS #
Overall 104 of 126
Sector (Life Science) 4 of 6
Type (Add-on Acquisition) 23 of 30
Country (United Kingdom) 68 of 72
Year (2015) 7 of 7
Size (of disclosed) 3 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-31 Tractel

Foetz, Luxembourg

Tractel provides lifting and access-related products. This includes lifting, material handling, measurement of tension and loads, suspended working platforms, building maintenance installations and fall arrest safety equipment. Tractel was founded in 1941 and is based in Foetz, Luxembourg.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-23 ERGO Italia

Milan, Italy

ERGO Italia operates both life and non-life insurance products. ERGO Italia was founded in 1986 and is based in Milan, Italy.

Buy -
Mergr

Product

Company

Legal